• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突变型二氢蝶啶还原酶的结构和机制特性改变

Altered structural and mechanistic properties of mutant dihydropteridine reductases.

作者信息

Kiefer P M, Varughese K I, Su Y, Xuong N H, Chang C F, Gupta P, Bray T, Whiteley J M

机构信息

University of California at San Diego, La Jolla, California 92093-0317, USA.

出版信息

J Biol Chem. 1996 Feb 16;271(7):3437-44. doi: 10.1074/jbc.271.7.3437.

DOI:10.1074/jbc.271.7.3437
PMID:8631945
Abstract

Nine single genetic mutants of rat dihydropteridine reductase (EC 1.6.99.7), D37I, W86I, Y146F, Y146H, K150Q, K150I, K150M, N186A, and A133S and one double mutant, Y146F/K150Q, have been engineered, overexpressed in Escherichia coli and their proteins purified. Of these, five, W86I, Y146F, Y146H, Y146F/K150Q, and A133S, have been crystallized and structurally characterized. Kinetic constants for each of the mutant enzyme forms, except N186A, which was too unstable to isolate in a homogeneous form, have been derived and in the five instances where structures are available the altered activities have been interpreted by correlation with these structures. It is readily apparent that specific interactions of the apoenzyme with the cofactor, NADH, are vital to the integrity of the total protein tertiary structure and that the generation of the active site requires bound cofactor in addition to a suitably placed W86. Thus when the three major centers for hydrogen bonding to the cofactor are mutated, i.e. 37, 150, and 186, an unstable partially active enzyme is formed. It is also apparent that tyrosine 146 is vital to the activity of the enzyme, as the Y146F mutant is almost inactive having only 1.1% of wild-type activity. However, when an additional mutation, K150Q, is made, the rearrangement of water molecules in the vicinity of Lys150 is accompanied by the recovery of 50% of the wild-type activity. It is suggested that the involvement of a water molecule compensates for the loss of the tyrosyl hydroxyl group. The difference between tyrosine and histidine groups at 146 is seen in the comparably unfavorable geometry of hydrogen bonds exhibited by the latter to the substrate, reducing the activity to 15% of the wild type. The mutant A133S shows little alteration in activity; however, its hydroxyl substituent contributes to the active site by providing a possible additional proton sink. This is of little value to dihydropteridine reductase but may be significant in the sequentially analogous short chain dehydrogenases/reductases, where a serine is the amino acid of choice for this position.

摘要

已构建了大鼠二氢蝶啶还原酶(EC 1.6.99.7)的9个单基因突变体,即D37I、W86I、Y146F、Y146H、K150Q、K150I、K150M、N186A和A133S,以及1个双基因突变体Y146F/K150Q。这些突变体在大肠杆菌中过表达,并对其蛋白质进行了纯化。其中,W86I、Y146F、Y146H、Y146F/K150Q和A133S这5个突变体已结晶并进行了结构表征。除N186A因过于不稳定而无法以均一形式分离外,已得出了每种突变酶形式的动力学常数,并且在有结构数据的5个实例中,通过与这些结构的关联解释了活性的改变。很明显,脱辅基酶与辅因子NADH的特异性相互作用对于整个蛋白质三级结构的完整性至关重要,并且活性位点的形成除了需要合适定位的W86外,还需要结合的辅因子。因此,当与辅因子形成氢键的三个主要中心发生突变,即37、150和186位时,会形成不稳定的部分活性酶。同样明显的是,酪氨酸146对酶的活性至关重要,因为Y146F突变体几乎无活性,仅具有野生型活性的1.1%。然而,当进行额外的K150Q突变时,Lys150附近水分子的重排伴随着50%野生型活性的恢复。有人认为水分子的参与补偿了酪氨酰羟基的损失。146位酪氨酸和组氨酸残基之间的差异体现在后者与底物形成的氢键几何结构相对不利,使活性降至野生型的15%。突变体A133S的活性几乎没有变化;然而,其羟基取代基通过提供一个可能的额外质子受体对活性位点有贡献。这对二氢蝶啶还原酶的价值不大,但在顺序类似的短链脱氢酶/还原酶中可能很重要,在这些酶中丝氨酸是该位置的首选氨基酸。

相似文献

1
Altered structural and mechanistic properties of mutant dihydropteridine reductases.突变型二氢蝶啶还原酶的结构和机制特性改变
J Biol Chem. 1996 Feb 16;271(7):3437-44. doi: 10.1074/jbc.271.7.3437.
2
Characterization and nucleotide binding properties of a mutant dihydropteridine reductase containing an aspartate 37-isoleucine replacement.
J Biol Chem. 1992 Aug 5;267(22):15334-9.
3
Role of aspartate-37 in determining cofactor specificity and binding in rat liver dihydropteridine reductase.
Arch Biochem Biophys. 1991 Jun;287(2):234-9. doi: 10.1016/0003-9861(91)90412-c.
4
cys-->ser mutations in ch-human dihydropteridine reductase.人二氢蝶啶还原酶中半胱氨酸到丝氨酸的突变。
Adv Exp Med Biol. 1993;338:131-4. doi: 10.1007/978-1-4615-2960-6_26.
5
Structural and mechanistic implications of incorporating naturally occurring aberrant mutations of human dihydropteridine reductase into a rat model.将人类二氢蝶啶还原酶的天然异常突变纳入大鼠模型的结构和机制意义。
Int J Pept Protein Res. 1994 Sep;44(3):278-87. doi: 10.1111/j.1399-3011.1994.tb00171.x.
6
The crystallographic structure of a human dihydropteridine reductase NADH binary complex expressed in Escherichia coli by a cDNA constructed from its rat homologue.
J Biol Chem. 1993 Dec 25;268(36):26836-41. doi: 10.2210/pdb1hdr/pdb.
7
The comparative interaction of quinonoid (6R)-dihydrobiopterin and an alternative dihydropterin substrate with wild-type and mutant rat dihydropteridine reductases.醌型(6R)-二氢生物蝶呤与另一种二氢蝶呤底物与野生型和突变型大鼠二氢蝶啶还原酶的比较相互作用。
Biochemistry. 1997 Aug 5;36(31):9438-45. doi: 10.1021/bi970585i.
8
Structural and mechanistic characteristics of dihydropteridine reductase: a member of the Tyr-(Xaa)3-Lys-containing family of reductases and dehydrogenases.二氢蝶啶还原酶的结构和机制特征:含Tyr-(Xaa)3-Lys还原酶和脱氢酶家族的成员
Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5582-6. doi: 10.1073/pnas.91.12.5582.
9
Tyrosine-48 is the proton donor and histidine-110 directs substrate stereochemical selectivity in the reduction reaction of human aldose reductase: enzyme kinetics and crystal structure of the Y48H mutant enzyme.酪氨酸-48是质子供体,组氨酸-110在人醛糖还原酶的还原反应中指导底物立体化学选择性:Y48H突变酶的酶动力学和晶体结构。
Biochemistry. 1994 Mar 1;33(8):2021-32. doi: 10.1021/bi00174a007.
10
Mutagenesis of Escherichia coli acetohydroxyacid synthase isoenzyme II and characterization of three herbicide-insensitive forms.大肠杆菌乙酰羟酸合酶同工酶II的诱变及三种除草剂不敏感形式的特性分析
Biochem J. 1998 Nov 1;335 ( Pt 3)(Pt 3):653-61. doi: 10.1042/bj3350653.

引用本文的文献

1
QDPR gene mutation and clinical follow-up in Chinese patients with dihydropteridine reductase deficiency.中国二氢蝶啶还原酶缺乏症患者的QDPR基因突变与临床随访
World J Pediatr. 2014 Aug;10(3):219-26. doi: 10.1007/s12519-014-0496-7. Epub 2014 Aug 15.
2
Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4.心肌缺血导致四氢生物蝶呤(BH4)氧化,内皮功能受损,而BH4可改善这种情况。
Proc Natl Acad Sci U S A. 2007 Sep 18;104(38):15081-6. doi: 10.1073/pnas.0702986104. Epub 2007 Sep 11.